|
mRNA_ID
|
Gene Name
|
drug_ID
|
drug_Name
|
Disease
|
RNA_exp_pattern
|
Evidence
|
Details
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
esophageal squamous cell carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
melanoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
non-small cell lung cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
thyroid cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
breast cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
cervical cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
laryngeal cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
breast cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
urothelial cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
pancreatic cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
ovarian cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
nasopharyngeal carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
hypopharyngeal cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
non-small cell lung cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
non-small cell lung cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
melanoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
pituitary tumor
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
breast cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
melanoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
colorectal cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
hepatocellular carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
colorectal cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
glioblastoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
T-cell acute lymphoblastic leukaemia
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
colorectal cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
breast cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
non-small cell lung cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
hepatic cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
hepatocellular carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
breast cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
colorectal cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
malignant melanoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
prostate cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
colorectal cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
colorectal cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
NA
|
gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000261769
|
CDH1
|
DB00412
|
Rosiglitazone
|
hepatocellular carcinoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1
|
DB00331
|
Metformin
|
enteritis
|
up-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1
|
DB01590
|
Everolimus
|
pulmonary fibrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1
|
DB04297
|
Trichostatin A
|
chronic airway disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1
|
DB04297
|
Trichostatin A
|
chronic rhinosinusitis
|
down-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1
|
DB07715
|
Emodin
|
pancreatic cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1
|
DB01169
|
Arsenic trioxide
|
prostatic cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1
|
DB11672
|
Curcumin
|
prostatic cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
Lathyrol derivatives
|
non-small cell lung cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
Anhydroicaritin
|
breast cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1
|
DB16865
|
Rosmarinic acid
|
pancreatic ductal adenocarcinoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1
|
NA
|
Costunolide
|
non small cell lung cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1
|
DB01590
|
Everolimus
|
breast cancers
|
down-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1 (E-cadherin)
|
DB01262
|
5-Aza-2-deoxycytidine (5-Aza-CdR)
|
colorectal cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1 (E-cadherin)
|
NA
|
Baicalein
|
lung cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1 (E-cadherin)
|
DB07715 (DB12653)
|
Emodin
|
colon cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1 (E-cadherin)
|
NA
|
JZL184
|
colon cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1 (E-cadherin)
|
NA
|
3-deazaneplanocin A
|
pancreatic cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1 (E-cadherin)
|
NA
|
Enterolactone
|
breast cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1 (E-cadherin)
|
DB11544
|
Salinomycin
|
colorectal cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000261769
|
CDH1 (E-cadherin)
|
DB00136 (NUTR00003, APRD00246, DB05314)
|
Calcitriol (1-alpha-25-Dihydroxyvitamin D3)
|
breast cancer
|
up-regulated
|
validated
|
more...
|